شرکت سرمایه گذاری داروئی تامین
@i_16012
What symbols does the trader recommend buying?
Purchase History
پیام های تریدر
Filter
Signal Type
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company has bought 1797.007 million shares on 24/03/24 and currently holds 24.186 % of Delzharavi shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 1797.007 million shares on 21/03/21 and currently holds 24.186 % of Delzharavi shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 2249.623 million shares on 14/02/16 and currently accounts for 7.977 % of the discharge shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 2983.829 million minutes on 14/02/09 and currently holds 36.432 % of the stock in its equity portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 1543.579 million shares on 14/12/28 and currently accounts for 63.645 % of the stock in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 57.907 million shares on 14/11/28 and currently accounts for 4.136 % of Dafra's shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company has sold 3.600 million shares of Claire on 14/10/04 and currently accounts for 71.723 % of Claire's shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Danaa Pharmaceutical Investment Company purchased 1667.306 million shares on 14/10/02 and currently holds 34.735 % of Danaa's shares in its portfolio.
شرکت سرمایه گذاری داروئی تامین
The Caspian Pharmaceutical Investment Company has sold 7.778 million shares on 14/09/18 and currently holds 72.585 % of Caspian shares in its corporate portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company has sold 2,000 million shares of Claire on 14/09/12 and currently accounts for 72.964 % of Claire's shares in its joint portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.